# Hertility Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hertility-health

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: www.hertilityhealth.com
- Total disclosed funding: $5.9M
- Latest round: Seed (Jun 15, 2021)
- Investors on record: 2

## About

Hertility Health Limited, based in London, UK, specializes in advanced hormone and fertility testing for women, providing essential insights into reproductive health since its inception in 2019.Established in London, UK, in 2019, Hertility Health Limited focuses on providing at-home hormone and fertility testing services for women. The company was co-founded by Deirdre O'Neill, Helen O'Neill, and Natalie Getreu, with Helen O'Neill currently serving as CEO. In June 2021, the company raised GBP 4.2 million in Seed funding led by LocalGlobe, with participation from Venrex Investment Management and individual investors. This funding round is the sole investment round the company has completed, totaling GBP 4.2 million raised.Hertility Health specializes in at-home hormone and fertility testing for women, offering various diagnostic services to address reproductive health concerns. Their core product, the Advanced Hormone and Fertility Test, delivers clinical-grade results within six days. Additional services include consultations with fertility advisors, pelvic ultrasound scans, private gynecologist consultations, and nutrition consultations tailored for pre-conception and pregnancy. The company primarily serves customers in the United Kingdom and aims to expand its geographical reach focusing on women's health and fertility solutions.Hertility Health generates revenue through direct-to-consumer transactions for personalized testing and consultation services. Clients pay for individual tests and consultations, which include structured pricing for specific offerings like the Advanced Hormone and Fertility Test and Fertility Advisor Call. These services are designed to provide comprehensive care, including a doctor-written report and a tailored clinical care plan, emphasizing a consumer-centric approach through direct sales channels.Following its Seed funding round in June 2021, which raised GBP 4.2 million, Hertility Health plans to utilize the funds to expand its product offerings and enhance its clinical trials, aiming to reduce diagnosis times for common reproductive conditions. The company is also exploring opportunities to enter new markets, focusing on broader geographical regions, particularly those with unmet needs in women's health and fertility solutions.

## Funding rounds

- Seed, Jun 15, 2021, $5.9M — Venrex, LocalGlobe

## Investors

- Venrex (https://capitalatlas.ai/funds/venrex) — Seed
- LocalGlobe (https://capitalatlas.ai/funds/localglobe) — Seed